Nanochon secures Panamá’s approval for trial of knee cartilage implant

Nanochon has received approval from Panama's Ministry of Health to initiate a first-in-human clinical trial of its Chondrograft implant, a knee cartilage device. The trial represents an early-stage advancement for the company's regenerative orthopedic technology, marking progression toward potential commercialization in the region.